Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Adult Stem Cells

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Parent and professional experiences of a clinical trial of prenatal and postnatal stem cell therapy for severe osteogenesis imperfecta.

European journal of human genetics : EJHG·2026

Same author

Predicting outcomes in selective fetal growth restriction of monoChOrioNic Twins: an inteRnAtional observational cohort STudy protocol (CONTRAST study).

BMJ open·2026

Same author

Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn.

NEJM evidence·2026

Same author

Prospective Double-Blind Randomized Study of Single Dose Bone Marrow-Derived Mesenchymal Stromal Cells versus Placebo for Steroid-Refractory Acute Graft-Versus-Host Disease.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2025

Same author

Placental intervillous blood harbors NK cells with distinct tissue-resident characteristics.

Mucosal immunology·2025

Same author

Biologics in red cell and platelet alloimmunizations: State of the science and future perspectives.

Best practice & research. Clinical obstetrics & gynaecology·2025

Search research articles

Related Experiment Video

Updated: Jul 9, 2026

Generation of Neural Stem Cells from Discarded Human Fetal Cortical Tissue

Generation of Neural Stem Cells from Discarded Human Fetal Cortical Tissue

Published on: May 25, 2011

Fetal stem-cell transplantation.

Eleonor Tiblad¹, Magnus Westgren

¹Center for Fetal Medicine, Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden.

Best Practice & Research. Clinical Obstetrics & Gynaecology

|November 24, 2007

Summary

This summary is machine-generated.

Fetal stem-cell transplantation offers a promising treatment for diseases before birth. The fetus

More Related Videos

Protocol for the Direct Conversion of Murine Embryonic Fibroblasts into Trophoblast Stem Cells

Protocol for the Direct Conversion of Murine Embryonic Fibroblasts into Trophoblast Stem Cells

Published on: July 25, 2016

Fate Mapping of Human Embryonic Stem Cells by Teratoma Formation

Fate Mapping of Human Embryonic Stem Cells by Teratoma Formation

Published on: August 1, 2010

Related Experiment Videos

Last Updated: Jul 9, 2026

Generation of Neural Stem Cells from Discarded Human Fetal Cortical Tissue

Generation of Neural Stem Cells from Discarded Human Fetal Cortical Tissue

Published on: May 25, 2011

Protocol for the Direct Conversion of Murine Embryonic Fibroblasts into Trophoblast Stem Cells

Protocol for the Direct Conversion of Murine Embryonic Fibroblasts into Trophoblast Stem Cells

Published on: July 25, 2016

Fate Mapping of Human Embryonic Stem Cells by Teratoma Formation

Fate Mapping of Human Embryonic Stem Cells by Teratoma Formation

Published on: August 1, 2010

Area of Science:

Regenerative Medicine
Immunology
Developmental Biology

Background:

Fetal stem-cell transplantation is a potential therapeutic strategy for congenital hematological, metabolic, and immunological disorders.
Early in-utero transplantation leverages natural fetal stem cell migration and development for improved engraftment.
The developing fetal immune system exhibits a reduced capacity to respond to allogeneic cells compared to adults.

Purpose of the Study:

To explore the potential of fetal stem-cell transplantation as a prenatal treatment modality.
To investigate the induction of immune tolerance to alloantigens in the fetal environment.
To assess the feasibility of transplantation without myeloablation.

Main Methods:

Utilized fetal stem cells for transplantation in a preclinical model.
Assessed immune responses and tolerance induction post-transplantation.
Evaluated the efficacy of the approach in addressing specific disease models.

Main Results:

Demonstrated the feasibility of delivering and engrafting fetal stem cells.
Observed an impaired immune response to allogeneic cells in the fetal setting.
Showcased the potential for inducing alloantigen tolerance without myeloablative conditioning.

Conclusions:

Fetal stem-cell transplantation is a viable and promising therapeutic approach for prenatal treatment of various diseases.
The immature fetal immune system facilitates tolerance induction, reducing the need for aggressive conditioning regimens.
Further research is warranted to overcome potential immune barriers and optimize clinical application.